Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 389 | 117 | 1 | 2 | 16 |
| Cost of Goods | 0 | 0 | 0 | 139 | 30 |
| Gross Profit | 389 | 117 | 1 | -137 | -14 |
| Operating Expenses | 339 | 1,094 | 3,446 | 1,964 | 2,171 |
| Operating Income | 50 | -977 | -3,444 | -1,962 | -2,155 |
| Interest Expense | 220 | 260 | 685 | 1,103 | 1,219 |
| Other Income | 36 | -147 | 148 | -90 | 4 |
| Pre-tax Income | -134 | -1,384 | -3,981 | -3,154 | -3,369 |
| Income Tax | 0 | -111 | N/A | 175 | -1 |
| Net Income Continuous | -134 | -1,273 | -3,981 | -3,330 | -3,368 |
| Minority Interests | 52 | -260 | -48 | -219 | -51 |
| Net Income | $-187 | $-1,013 | $-3,933 | $-3,111 | $-3,318 |
| EPS Basic Total Ops | -0.02 | -0.09 | -0.40 | -0.38 | -0.82 |
| EPS Basic Continuous Ops | -0.01 | -0.11 | -0.41 | -0.41 | -0.83 |
| EPS Diluted Total Ops | -0.02 | -0.09 | -0.40 | -0.38 | -0.82 |
| EPS Diluted Continuous Ops | -0.01 | -0.11 | -0.41 | -0.41 | -0.83 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.09 | -0.40 | -0.35 | -0.82 |
| EBITDA(a) | $57 | $-963 | $-3,443 | $-1,954 | $-2,147 |